PMC:7534795 / 1554-1712 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T23","span":{"begin":45,"end":50},"obj":"Chemical"},{"id":"T24","span":{"begin":61,"end":72},"obj":"Chemical"},{"id":"T25","span":{"begin":107,"end":112},"obj":"Chemical"},{"id":"T26","span":{"begin":126,"end":134},"obj":"Chemical"}],"attributes":[{"id":"A23","pred":"chebi_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_25212"},{"id":"A25","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A26","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"}],"text":"idering the favorable safety profile for n-3 PUFAs and their metabolites, it is reasonable to consider n-3 PUFAs as potential adjuvant therapies for the clini"}

{"project":"LitCovid-PubTator","denotations":[{"id":"49","span":{"begin":41,"end":50},"obj":"Chemical"},{"id":"50","span":{"begin":103,"end":112},"obj":"Chemical"}],"attributes":[{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"MESH:D015525"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"MESH:D015525"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"idering the favorable safety profile for n-3 PUFAs and their metabolites, it is reasonable to consider n-3 PUFAs as potential adjuvant therapies for the clini"}